XTLB logo

XTL Biopharmaceuticals (XTLB) Revenue

Annual Revenue

N/A

December 31, 2023


Summary


Performance

XTLB Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherXTLBprofitabilitymetrics:

Quarterly Revenue

$162.00 K
NaN%

September 30, 2024


Summary


Performance

XTLB Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

TTM Revenue

$162.00 K
NaN%

September 30, 2024


Summary


Performance

XTLB TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherXTLBprofitabilitymetrics:

XTLB Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

XTLB Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat lowat highat low
5 y5-yearat highat lowat highat low
alltimeall time-91.9%+109.8%-97.3%-100.0%

XTL Biopharmaceuticals Revenue History

DateAnnualQuarterlyTTM
Sep 2024
-
$162.00 K(-109.8%)
$162.00 K(>+9900.0%)
Dec 2013
-
-$1.66 M(-450.5%)
$0.00(-100.0%)
Sep 2013
-
$473.00 K(-7.6%)
$1.31 M(+11.0%)
Jun 2013
-
$512.00 K(-23.9%)
$1.19 M(+76.1%)
Mar 2013
-
$673.00 K(-296.2%)
$673.00 K(>+9900.0%)
Dec 2012
-
-$343.00 K(-200.0%)
$0.00(-100.0%)
Sep 2012
-
$343.00 K(-82.8%)
$343.00 K(-94.2%)
Dec 2008
$5.94 M(+554.9%)
-
-
Sep 2008
-
$2.00 M(+1.5%)
$5.94 M(+42.6%)
Jun 2008
-
$1.97 M(0.0%)
$4.17 M(+80.3%)
Mar 2008
-
$1.97 M(+771.7%)
$2.31 M(+307.4%)
Dec 2007
$907.00 K
-
-
Sep 2007
-
$226.00 K(+98.2%)
$567.00 K(+24.6%)
DateAnnualQuarterlyTTM
Jun 2007
-
$114.00 K(0.0%)
$455.00 K(0.0%)
Mar 2007
-
$114.00 K(+0.9%)
$455.00 K(0.0%)
Dec 2006
$454.00 K(-85.8%)
$113.00 K(-0.9%)
$455.00 K(-28.5%)
Sep 2006
-
$114.00 K(0.0%)
$636.00 K(-22.2%)
Jun 2006
-
$114.00 K(0.0%)
$817.00 K(-59.6%)
Mar 2006
-
$114.00 K(-61.2%)
$2.02 M(-37.1%)
Dec 2005
$3.20 M(-7.4%)
$294.00 K(-0.3%)
$3.21 M(-15.0%)
Sep 2005
-
$295.00 K(-77.6%)
$3.78 M(-13.1%)
Jun 2005
-
$1.32 M(+1.1%)
$4.35 M(+28.3%)
Mar 2005
-
$1.30 M(+51.3%)
$3.39 M(+14.9%)
Dec 2004
$3.45 M
$862.00 K(-0.2%)
$2.95 M(+41.3%)
Sep 2004
-
$864.00 K(+140.7%)
$2.09 M(+70.6%)
Jun 2004
-
$359.00 K(-58.4%)
$1.22 M(+41.6%)
Mar 2004
-
$864.00 K
$864.00 K

FAQ

  • What is the all time high annual revenue for XTL Biopharmaceuticals?
  • What is XTL Biopharmaceuticals quarterly revenue?
  • What is the all time high quarterly revenue for XTL Biopharmaceuticals?
  • What is XTL Biopharmaceuticals TTM revenue?
  • What is the all time high TTM revenue for XTL Biopharmaceuticals?

What is the all time high annual revenue for XTL Biopharmaceuticals?

XTL Biopharmaceuticals all-time high annual revenue is $5.94 M

What is XTL Biopharmaceuticals quarterly revenue?

The current quarterly revenue of XTLB is $162.00 K

What is the all time high quarterly revenue for XTL Biopharmaceuticals?

XTL Biopharmaceuticals all-time high quarterly revenue is $2.00 M

What is XTL Biopharmaceuticals TTM revenue?

The current TTM revenue of XTLB is $162.00 K

What is the all time high TTM revenue for XTL Biopharmaceuticals?

XTL Biopharmaceuticals all-time high TTM revenue is $5.94 M